文献速递针灸推拿中医内科中药与中成药合理使用

安神镇静针刺治疗阿尔茨海默病伴睡眠障碍的疗效与穴位特异性:三臂随机对照试验方案

Efficacy and acupoint specificity of sedative-tranquilizing acupuncture for Alzheimer's disease with sleep disorders: A three-arm randomized controlled trial protocol.
PubMed 文献 · Complement Ther Med · 2026-03-29

针对阿尔茨海默病(AD)伴睡眠障碍(SD)患者,设计多中心三臂随机对照试验,纳入72例受试者,按1:1:1分为对照组(多奈哌齐联合失眠认知行为治疗)、针刺组(加安神镇静针刺)和假针刺组(加假针刺),以匹兹堡睡眠质量指数(PSQI)变化为主要结局,评估针刺的协同价值与睡眠-认知共调节效应。

要点

  • 安神镇静针刺作为AD伴睡眠障碍的辅助非药物疗法,其疗效与穴位特异性尚待验证。
  • 主要结局为PSQI评分变化,次要结局包括MMSE、AD-QOL、HAMA和HAMD-17。
  • 将分析外周生化标志物、多导睡眠图参数和神经影像数据以探索机制。

核心结论

  • 该试验旨在为安神镇静针刺能否有效辅助改善AD-SD共病患者睡眠质量与认知功能提供临床证据,并阐释针刺的潜在神经生物学机制。

研究设计与样本

  • 多中心、随机、对照试验方案,纳入72例同时诊断为AD和SD的参与者,按1:1:1随机分为对照组、针刺组和假针刺组。

关键数值与推荐

  • 对照组接受标准治疗(盐酸多奈哌齐联合失眠认知行为治疗[CBT-I])。
  • 针刺组在标准治疗基础上加安神镇静针刺,假针刺组加假针刺联合标准治疗。
  • 主要结局为PSQI评分较基线的变化,次要结局包括MMSE、AD-QOL、HAMA和HAMD-17。

临床怎么用

  • 该方案为AD伴睡眠障碍患者提供了一种潜在的中西医结合非药物干预策略,即标准治疗联合安神镇静针刺。

局限性

  • 本文为试验方案,尚无疗效结果;样本量72例,结论需待试验完成后确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sleep disorders (SD) are highly prevalent in patients with Alzheimer's disease (AD); however, effective pharmacological interventions are often limited by adverse effects or insufficient efficacy. This study aims to evaluate the clinical synergistic value and the "sleep-cognition co-modulation" effect of sedative-tranquilizing acupuncture, a specialized non-pharmacological therapy, in managing AD-SD comorbidity. PARTICIPANTS AND METHODS: This is a multicenter, randomized, controlled trial (RCT) involving 72 participants diagnosed with both AD and SD. Participants will be randomly assigned (1:1:1) to one of three groups: the control group, receiving standard care (donepezil hydrochloride combined with cognitive behavioral therapy for insomnia [CBT-I]); the acupuncture group, receiving sedative-tranquilizing acupuncture in addition to standard care; and the sham acupuncture group, receiving sham acupuncture plus standard care. The primary outcome measure is the change from baseline in the Pittsburgh Sleep Quality Index (PSQI) score. Secondary outcomes include cognitive function (Mini-Mental State Examination [MMSE]), quality of life (Quality of Life in Alzheimer's Disease [AD-QOL] scale), and psychological symptoms (Hamilton Anxiety Scale [HAMA] and the 17-item Hamilton Depression Scale [HAMD-17]). Furthermore, peripheral biochemical markers, polysomnography (PSG) parameters, and neuroimaging data will be analyzed to explore underlying mechanisms. All analyses will be performed on an intention-to-treat (ITT) basis. CONCLUSIONS: This trial is expected to provide robust clinical evidence regarding whether sedative-tranquilizing acupuncture can effectively assist in improving sleep quality and cognitive function in patients with AD-SD comorbidity. The findings will further elucidate the potential neurobiological mechanisms of acupuncture and offer a novel integrative strategy for the management of AD-related sleep disturbances. TRIAL REGISTRATION: This protocol was approved by the Ethics Committee of Nanchang Hongdu Hospital of Traditional Chinese Medicine (KYKS-2024044-1(X-2) and registered with the International Traditional Medicine Clinical Trial Registry (https://itmctr.ccebtcm.org.cn/mgt/project/user/user-project-view/09DB9DBC-F576-4AF9-AF4E-D6D88E1B1B6B).

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Liu H, Zhong XC, Xiong J, et al. Efficacy and acupoint specificity of sedative-tranquilizing acupuncture for Alzheimer's disease with sleep disorders: A three-arm randomized controlled trial protocol. Complement Ther Med. 2026. PMID: 41916432. doi:10.1016/j.ctim.2026.103366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。